Codex DNA Inc (DNAY)

6.80 +0.06  +0.89% NASDAQ Nov 26, 16:00 USD

Codex DNA Cash from Operations (TTM):

-28.82M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -28.82M
June 30, 2021 -20.13M
March 31, 2021 -17.10M
Dec. 31, 2020 -15.38M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

LENSAR Inc -10.23M
Eargo Inc -41.46M
Movano Inc -13.60M

Cash from Operations (TTM) Range, Past 5 Years

Minimum -28.82M Sep 2021
Maximum -15.38M Dec 2020
Average -20.36M


Codex DNA acquires Eton Bioscience for ~$13M
SA Breaking News 11/10 06:17 ET
Codex DNA Acquires Eton Bioscience
Globe Newswire 11/09 16:15 ET
--Cowen Starts Codex DNA at Outperform
MT Newswires 07/13 06:53 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.